Ridgetech EBITDA Margin 2012-2025 | RDGT

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Ridgetech (RDGT) over the last 10 years. The current EBITDA margin for Ridgetech as of September 30, 2025 is .
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Ridgetech EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2021-03-31 $0.13B $-0.01B -5.22%
2020-12-31 $0.13B $-0.01B -7.03%
2020-09-30 $0.13B $0.00B -1.60%
2020-06-30 $0.12B $0.00B -1.64%
2020-03-31 $0.12B $0.00B -3.45%
2019-12-31 $0.11B $0.00B 1.79%
2019-09-30 $0.11B $0.00B -0.91%
2019-06-30 $0.11B $0.00B -0.92%
2019-03-31 $0.11B $0.00B 0.93%
2018-12-31 $0.11B $-0.01B -13.33%
2018-09-30 $0.10B $-0.01B -13.86%
2018-06-30 $0.10B $-0.01B -14.43%
2018-03-31 $0.10B $-0.02B -15.63%
2017-12-31 $0.09B $-0.01B -7.61%
2017-09-30 $0.09B $-0.01B -5.81%
2017-06-30 $0.08B $0.00B -4.82%
2017-03-31 $0.08B $0.00B -3.66%
2016-12-31 $0.08B 0 0.00%
2016-09-30 $0.09B 0 0.00%
2016-06-30 $0.09B 0 0.00%
2016-03-31 $0.09B $0.00B 1.12%
2015-12-31 $0.09B $0.00B 4.44%
2015-09-30 $0.09B $0.01B 5.81%
2015-06-30 $0.08B $0.01B 6.17%
2015-03-31 $0.08B $0.00B 5.26%
2014-12-31 $0.07B $-0.01B -9.86%
2014-09-30 $0.07B $-0.02B -23.53%
2014-06-30 $0.07B $-0.02B -23.88%
2014-03-31 $0.07B $-0.02B -24.24%
2013-12-31 $0.06B $-0.02B -26.56%
2013-09-30 $0.06B $-0.01B -19.35%
2013-06-30 $0.07B $-0.01B -13.89%
2013-03-31 $0.09B $-0.01B -10.00%
2012-12-31 $0.10B $0.00B 1.98%
2012-09-30 $0.11B $0.01B 7.21%
2012-06-30 $0.11B $0.01B 8.49%
2012-03-31 $0.09B $0.01B 13.83%
2011-12-31 $0.09B $0.01B 15.56%
2011-09-30 $0.08B $0.01B 17.07%
2011-06-30 $0.08B $0.01B 18.42%
2011-03-31 $0.07B $0.01B 17.14%
2010-12-31 $0.07B $0.03B 38.46%
2010-09-30 $0.06B $0.03B 41.94%
2010-06-30 $0.06B $0.03B 43.10%
Sector Industry Market Cap Revenue
Retail/Wholesale Retail - Drug Stores $0.002B $0.120B
China Jo-Jo Drugstores, Inc., through its contractually controlled affiliates, operates a retail pharmacy chain in China offering both western and traditional Chinese medicine. Its contractually controlled affiliates include Hangzhou Jiuzhou Grand Pharmacy Chain Co., Ltd., Hangzhou Jiuzhou Clinic of Integrated Traditional and Western Medicine General Partnership, and Hangzhou Jiuzhou Medical & Public Health Service Co., Ltd. The chain has stores throughout Hangzhou, the provincial capital of Zhejiang Province.
Stock Name Country Market Cap PE Ratio
Herbalife (HLF) Cayman Islands $1.575B 7.15
GNC Holdings (GNC) United States $0.000B 0.00